US45256X1037
US45256X1037
ImmunityBio, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 113.288.000 | 14.745.000 | 668.3% |
| Cost of Revenue | 753.000 | -- | -- |
| Gross Profit | 112.535.000 | 14.745.000 | 663.2% |
| 368.562.000 | 358.927.000 | 2.7% | |
| Operating Income | -256.027.000 | -344.182.000 | 25.6% |
| Pretax Income | -351.607.000 | -413.645.000 | 15.0% |
| Net Income Common Stockholders | -351.398.000 | -413.564.000 | 15.0% |
| -- | -- | -- | |
| -- | -- | -- |